Biofrontera AG
BFFTF
$1.08
-$0.27-20.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 7.64M | 13.05M | 6.22M | 3.91M | 6.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.64M | 13.05M | 6.22M | 3.91M | 6.88M |
| Cost of Revenue | 1.35M | 2.52M | 1.34M | 917.50K | 1.10M |
| Gross Profit | 6.28M | 10.53M | 4.88M | 3.00M | 5.79M |
| SG&A Expenses | 2.74M | 3.85M | 3.83M | 3.95M | 2.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.61M | 8.64M | 7.14M | 7.10M | 5.41M |
| Operating Income | 1.03M | 4.41M | -925.50K | -3.19M | 1.47M |
| Income Before Tax | -2.66M | 1.32M | -3.64M | -2.59M | -4.65M |
| Income Tax Expenses | 757.50K | 965.50K | 84.70K | -222.70K | 494.70K |
| Earnings from Continuing Operations | -3.42M | 359.20K | -3.73M | -2.37M | -5.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.42M | 359.20K | -3.73M | -2.37M | -5.14M |
| EBIT | 1.03M | 4.41M | -925.50K | -3.19M | 1.47M |
| EBITDA | 1.08M | 4.62M | -875.40K | -3.14M | 1.54M |
| EPS Basic | -0.05 | 0.01 | -0.05 | -0.04 | -0.09 |
| Normalized Basic EPS | -0.03 | 0.01 | -0.03 | -0.03 | -0.05 |
| EPS Diluted | -0.05 | 0.01 | -0.05 | -0.04 | -0.09 |
| Normalized Diluted EPS | -0.03 | 0.01 | -0.03 | -0.03 | -0.05 |
| Average Basic Shares Outstanding | 62.82M | 56.30M | 69.50M | 60.25M | 56.70M |
| Average Diluted Shares Outstanding | 62.82M | 56.30M | 69.50M | 60.25M | 56.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
